General Archive
-
BlogsLearning to live with a bronchiectasis diagnosis – Gaynor’s story
Grandmother of 4, Gaynor Hardman, was diagnosed with bronchiectasis at 61. With limited knowledge and understanding of this condition, she…
-
News releasesLifeArc launches UK’s first cystic fibrosis Innovation Hub Network
The UK’s first network of Cystic Fibrosis Lung Health Innovation Hubs is being launched to accelerate the development of new…
-
AIRNET: A clinical trial to find new treatments for bronchiectasis
AIRNET: A clinical trial to find new treatments for bronchiectasis We have partnered with EMBARC and the University of Dundee…
-
News releasesFirst awardees of £3m collaborative Drug Discovery Programme are announced
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has announced the first cohort of awardees of its Collaborative Discovery Programme…
-
News releases
Drug trial offers hope to 200,000 people with ‘hidden’ lung condition
A multi-million-pound clinical trial, funded by LifeArc, to find out whether existing drugs could be used to treat people with…
-
BlogsRaising awareness of NTM pulmonary disease and its new Standards of Care
Today, 4 August is World Non-Tuberculous Mycobacteria (NTM) Awareness Day. A couple of years ago I had never heard of…
-
ArticlesBronchiectasis: an overlooked lung condition with untapped commercial and research potential
Bronchiectasis (BE) is a chronic lung condition that significantly impacts the lives of many people in the UK and around…
-
Bronchiectasis: a neglected and overlooked lung condition with unrealised commercial potential
Bronchiectasis: a neglected and overlooked lung condition with unrealised commercial potential We are collaborating with industry experts and Asthma +…
-
Accelerating CF Research
Accelerating CF Research: Strategies for rapidly progressing your science to clinical impact Join us at our industry symposium and unlock…
-
Funding: CF AMR Syndicate funding call for new cystic fibrosis therapies
Funding: CF AMR Syndicate funding call for new cystic fibrosis therapies LifeArc, as part of the CF AMR Syndicate, is…
-
Funding: Drug repurposing call to treat chronic respiratory infection
Funding: Drug repurposing call to treat chronic respiratory infection LifeArc has committed £10m to fund up to five consortia programmes…
-
News releasesLifeArc’s Edinburgh labs featured in STV segment about innovations for people living with bronchiectasis
Recently, our team had the pleasure of hosting STV for an exciting feature at the BioQuarter campus in Edinburgh. Watch…